United States · Biopharma startup
United States · Invetx
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.
Funding reportedLast round: Series B
What company datasets say Invetx raised
Funding, as reported
Reported in all$86Min dollars
Rounds3
Last roundSeries B
Last round dateMay 2022
Investors listed9
SEC Form D$71M sold, 2 filings, last Apr 2022
Founders and team
From the SEC filings it signed: 1 on the team.
- Jurgen HornExecutive Officer, Directori
On the board, as filediJason AkusJoachim HasenmaierPeter LeePhilip Austin
Biopharma in United States
Startups like it
Altos LabsSan Francisco · founded 2021
VaxcyteSan Carlos · founded 2013
Madrigal PharmaceuticalsConshohocken · founded 2011
Harmony BiosciencesPlymouth Meeting · founded 2017
Kura OncologyLa Jolla · founded 2014
ImmunovantNew York · founded 2018
SolugenHouston · founded 2016
Dianthus TherapeuticsWaltham · founded 2019
Is this your company?
Add your raise, your deck and your story, and put Invetx in front of investors. Or tell us what we have wrong.